# Haemonetics (HAE.US)

Canonical: https://gigainvestors.com/s/HAE

Analysis as of: 2026-10-16T07:28:56.564Z. Financial observations: FY1997–FY2026.

Listing currency: USD. Reporting currency: USD.

## Verdict

Not a wonderful business

Quality tests for Buy: not passed (profit record: pass; earnings resilience is evidence only). Published buy qualification: no.

Share price: $121.29 per share; close as of 2026-10-15.

Estimated value: low $47.23 per share, central $53.14 per share, high $61.02 per share. Buy at or below the central value $53.14 per share. Valuation as of 2026-10-16T07:28:56.564Z; scenarios are not confidence intervals.

Expected annual return: 5.9% at the stated quote. About 5.9% a year at today's price (required return 10.0%). required return 10.0% a year (10% floor; US 10-year bond 5.1% + 4 points).

## Checklist

### understandable: fail

- 3 revenue declines in the last 10 years (informational)

- operating margin variation exceeds 0.35

- Financial history: 10 years

- Years with declining revenue: 3

- Years with a net loss: 1

- Operating margin variation: 0.53×

Chart: Operating margin; fiscal year observations.

- FY2017: -0.02×

- FY2018: 0.06×

- FY2019: 0.09×

- FY2020: 0.10×

- FY2021: 0.10×

- FY2022: 0.08×

- FY2023: 0.13×

- FY2024: 0.13×

- FY2025: 0.16×

- FY2026: 0.18×

### moat: fail

- ROIC median below threshold

- ROIC worst years below threshold (more than 1 bad year allowed)

- ROIC, median of available years: 11.5%

- ROIC, second-lowest year: 6.9%

- Typical minus recent gross margin: -4.4 pp

- Typical gross margin (annual median): 51.3%

- Recent gross margin (lower of latest and 3-year median): 55.7%

- Years with nonpositive capital: 0

- Capital spending / revenue: 6.6%

- ROIC including acquisitions, ten-year median: 9.1%

Chart: ROIC excluding acquisitions; fiscal year observations.

- FY2017: -2.2%

- FY2018: 7.0%

- FY2019: 9.8%

- FY2020: 13.3%

- FY2021: 10.5%

- FY2022: 6.9%

- FY2023: 15.3%

- FY2024: 12.5%

- FY2025: 15.5%

- FY2026: 16.4%

### economics: pass

- Owner earnings / net income, 5-yr: 1.40×

- Cash conversion uses consolidated totals: No

- Owner earnings, five-year total: $757M

- Net income, five-year total: $541M

- Return on incremental invested capital: >100%

- Working capital / revenue, annual change: 0.4 pp

- Working capital / revenue, change between three-year averages: 4.4 pp

- Working capital / revenue, final three-year average: 35.5%

Chart: Annual owner cash / profit; fiscal year observations.

- FY2022: 1.03×

- FY2023: 1.00×

- FY2024: 1.50×

- FY2025: 1.46×

- FY2026: 1.81×

### management: pass

- Historical market-dollar context (not the management verdict): 2017 to 2026 (9 years)

- potential debt-funded buybacks (informational)

- buybacks leaned toward cheaper years (informational)

- ROIC first 3 years vs last 3 years: 7.0% vs 15.5%

- Per-share earnings: -0.51 to 2.29 (three-year endpoint medians)

- Management verdict uses per-share economic progress: Yes

- Ordinary dilution, 10-year annual growth: -1.0%

- Ordinary dilution, 5-year annual growth: -1.6%

- Market cap gain: $430M

- Cumulative retained earnings: -$11M

- Diluted shares, 10-year annual growth: -1.0%

- Diluted shares, 5-year annual growth: -1.6%

- $1 test, starting fiscal year: FY2017

- $1 test, ending fiscal year: FY2026

- Per-share value change: $2.80

- Per-share value, starting three-year median: -$0.51

- Per-share value, ending three-year median: $2.29

- Buybacks concentrated in cheaper years (correlation): 0.31

- Average buyback yield: 3.5%

- Buyback history: 8 years

- Debt-funded buybacks: Yes

- Acquisition spending: $855M

- Cumulative net income, 10 years: $772M

- ROIC, first three-year median: 7.0%

- ROIC, last three-year median: 15.5%

Chart: Earnings per share; fiscal year observations.

- FY2017: -$0.51

- FY2018: $0.85

- FY2019: $1.04

- FY2020: $1.48

- FY2021: $1.55

- FY2022: $0.84

- FY2023: $2.24

- FY2024: $2.29

- FY2025: $3.31

- FY2026: $2.05

### accounting: pass

- Sloan accruals: -8.2%

- Receivables to sales index (DSRI): 1.09×

- Restructuring years, last five: 1

- Stock compensation / operating cash flow: 11.5%

- Earnings backed by cash: Yes

- Operating cash / earnings: 3.01×

- Accounting red flags: 0

- Goodwill and intangibles / equity: 1.39×

Chart: Sloan accruals; fiscal year observations.

- FY2017: -15.0%

- FY2018: -14.1%

- FY2019: -8.2%

- FY2020: -6.4%

- FY2021: -1.6%

- FY2022: -6.9%

- FY2023: -8.1%

- FY2024: -2.9%

- FY2025: -0.6%

- FY2026: -8.2%

## Holders

- [John Rogers](https://gigainvestors.com/AI): tracked 13F investor; follow the investor page for holding quarter and amounts.

## Price story

Price needs cash profits to grow 11.9% a year for ten years · sales -2%

Story as of 2026-10-16T09:58:51.488Z; price observation 2026-10-15.

Price needs cash profits to grow 11.9% a year for ten years

- 2025-05-12: HAE Stock Gains on Q4 Earnings and Revenue Beat, Margins Up ([finance.yahoo.com](https://finance.yahoo.com/news/hae-stock-gains-q4-earnings-124000692.html))

- 2026-08-18: Haemonetics rises after supply deal with CSL ([seekingalpha.com](https://seekingalpha.com/news/4634234-haemonetics-stock-rises-supply-deal-csl?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news))

- 2026-09-22: Haemonetics (HAE) Could Be 66% Undervalued After Margin Expansion Focus ([finance.yahoo.com](https://finance.yahoo.com/markets/stocks/articles/haemonetics-hae-could-66-undervalued-221313485.html))

### Sales · FY2025–2026

sales -2%; source https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm; observed 2026-05-20.

- FY2017: $886M 

- FY2018: $904M 

- FY2019: $968M 

- FY2020: $988M 

- FY2021: $870M 

- FY2022: $993M 

- FY2023: $1.2B 

- FY2024: $1.3B 

- FY2025: $1.4B 

- FY2026: $1.3B 

### Gross margin · FY2026

gross margin 55.7%; source https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm; observed 2026-05-20.

- FY2017: 42.7% 

- FY2018: 45.6% 

- FY2019: 43.2% 

- FY2020: 49.4% 

- FY2021: 49.2% 

- FY2022: 53.4% 

- FY2023: 53.3% 

- FY2024: 54.4% 

- FY2025: 57.2% 

- FY2026: 55.7% 

## Owner memo

Memo as of 2026-10-16T08:06:05.509Z.

### How it makes money

Operates in medical devices; annual sales are USD 1.3 billion.

- Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm (filed 2026-05-20); FY2026: revenue 1334027000; grossProfit 743588000; margin = grossProfit / revenue.

### Why customers stay

Margins ranged from 54.4% to 57.2% during 2024–26; it earns 11.5% on its capital.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-05-20); FY2024: grossProfit / revenue = 54.4%.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-05-20); FY2025: grossProfit / revenue = 57.2%.

- Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm (filed 2026-05-20); FY2026: grossProfit / revenue = 55.7%.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-05-20); 10-year return on capital observations [[2017,-0.021753138443877405],[2018,0.06983409499889559],[2019,0.0978732228641497],[2020,0.13326784481535164],[2021,0.10543622686640108],[2022,0.06851427064997595],[2023,0.15283592275532917],[2024,0.124659550622065],[2025,0.15457971466028814],[2026,0.16394949174658358]]; median 0.11504788874423305. ROIC follows the displayed moat series; financial companies use return on tangible equity.

### Where the cash goes

Paid dividends in 3 of 10 years; bought back USD 175 million of shares.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-05-20); FY2018: growth capex 0; upkeep 74799000; owner earnings 60020000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-05-20); FY2019: growth capex 9543000; upkeep 109418000; owner earnings 55019000. Growth capex / owner earnings = 0.1734491721041822.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-05-20); FY2020: growth capex 0; upkeep 48758000; owner earnings 138057000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-05-20); FY2021: growth capex 0; upkeep 37040000; owner earnings 126716000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-05-20); FY2022: growth capex 0; upkeep 96509000; owner earnings 44613000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-05-20); FY2023: growth capex 16884000; upkeep 93307000; owner earnings 115401000. Growth capex / owner earnings = 0.14630722437413887.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-05-20); FY2024: growth capex 0; upkeep 38125000; owner earnings 176648000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-05-20); FY2025: growth capex 0; upkeep 39278000; owner earnings 243987000. Growth capex / owner earnings = 0.

- Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm (filed 2026-05-20); FY2026: growth capex 0; upkeep 32780000; owner earnings 176245000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-05-20); Dividend observations: [[2017,0],[2018,0],[2019,13445000],[2020,12016000],[2021,0],[2022,0],[2023,7016000],[2024,0],[2025,0],[2026,0]]. Zero only counted when supported by a complete cash-flow statement.

- Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm (filed 2026-05-20); FY2026: cash repurchases 175000000 USD.

### Are managers owners

Insiders own 1.3% of the company.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16); HAE.US SharesStats.PercentInsiders = 1.2630000000000001 percentage points; cache date 2026-10-16.

### What the price says

The price assumes cash profits grow 11.9% yearly over ten years.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-05-20); Ten-year compound average after fade. Initial solved rate 0.15868130112229417. Price 121.29; FX 1; discount 0.1; same standard ten-year fade to terminal 0.03. FY2016 owner earnings/share -1.3072951653455656 → FY2026 3.7218608776449718. Closing-price date 2026-10-15.

## Monthly share-price history (USD per share)

- 2016-10: $33.41 per share

- 2016-11: $39.63 per share

- 2016-12: $40.20 per share

- 2017-01: $39.86 per share

- 2017-02: $37.33 per share

- 2017-03: $40.57 per share

- 2017-04: $41.88 per share

- 2017-05: $40.78 per share

- 2017-06: $39.49 per share

- 2017-07: $41.13 per share

- 2017-08: $43.02 per share

- 2017-09: $44.87 per share

- 2017-10: $47.56 per share

- 2017-11: $57.80 per share

- 2017-12: $58.08 per share

- 2018-01: $64.65 per share

- 2018-02: $70.90 per share

- 2018-03: $73.16 per share

- 2018-04: $78.04 per share

- 2018-05: $90.35 per share

- 2018-06: $89.68 per share

- 2018-07: $97.64 per share

- 2018-08: $111.64 per share

- 2018-09: $114.58 per share

- 2018-10: $104.47 per share

- 2018-11: $107.28 per share

- 2018-12: $100.05 per share

- 2019-01: $98.91 per share

- 2019-02: $86.87 per share

- 2019-03: $87.48 per share

- 2019-04: $87.28 per share

- 2019-05: $96.99 per share

- 2019-06: $120.34 per share

- 2019-07: $122.08 per share

- 2019-08: $133.53 per share

- 2019-09: $126.14 per share

- 2019-10: $120.73 per share

- 2019-11: $120.60 per share

- 2019-12: $114.90 per share

- 2020-01: $107.39 per share

- 2020-02: $108.33 per share

- 2020-03: $99.66 per share

- 2020-04: $113.78 per share

- 2020-05: $109.68 per share

- 2020-06: $89.56 per share

- 2020-07: $87.66 per share

- 2020-08: $89.66 per share

- 2020-09: $87.25 per share

- 2020-10: $101.09 per share

- 2020-11: $112.85 per share

- 2020-12: $118.75 per share

- 2021-01: $114.29 per share

- 2021-02: $126.50 per share

- 2021-03: $111.01 per share

- 2021-04: $67.26 per share

- 2021-05: $56.46 per share

- 2021-06: $66.64 per share

- 2021-07: $60.79 per share

- 2021-08: $62.75 per share

- 2021-09: $70.59 per share

- 2021-10: $68.71 per share

- 2021-11: $51.25 per share

- 2021-12: $53.04 per share

- 2022-01: $48.35 per share

- 2022-02: $57.71 per share

- 2022-03: $63.22 per share

- 2022-04: $50.67 per share

- 2022-05: $63.26 per share

- 2022-06: $65.18 per share

- 2022-07: $69.49 per share

- 2022-08: $75.03 per share

- 2022-09: $74.03 per share

- 2022-10: $84.95 per share

- 2022-11: $85.31 per share

- 2022-12: $78.65 per share

- 2023-01: $84.60 per share

- 2023-02: $77.77 per share

- 2023-03: $82.75 per share

- 2023-04: $83.71 per share

- 2023-05: $84.60 per share

- 2023-06: $85.14 per share

- 2023-07: $92.24 per share

- 2023-08: $89.73 per share

- 2023-09: $89.58 per share

- 2023-10: $85.23 per share

- 2023-11: $80.87 per share

- 2023-12: $85.51 per share

- 2024-01: $76.46 per share

- 2024-02: $72.98 per share

- 2024-03: $85.35 per share

- 2024-04: $91.95 per share

- 2024-05: $84.08 per share

- 2024-06: $82.73 per share

- 2024-07: $90.05 per share

- 2024-08: $75.58 per share

- 2024-09: $80.38 per share

- 2024-10: $71.16 per share

- 2024-11: $87.47 per share

- 2024-12: $78.08 per share

- 2025-01: $69.05 per share

- 2025-02: $65.50 per share

- 2025-03: $63.55 per share

- 2025-04: $63.02 per share

- 2025-05: $67.71 per share

- 2025-06: $74.61 per share

- 2025-07: $74.04 per share

- 2025-08: $54.54 per share

- 2025-09: $48.74 per share

- 2025-10: $50.01 per share

- 2025-11: $81.35 per share

- 2025-12: $80.15 per share

- 2026-01: $66.66 per share

- 2026-02: $63.32 per share

- 2026-03: $56.36 per share

- 2026-04: $60.09 per share

- 2026-05: $67.81 per share

- 2026-06: $75.00 per share

- 2026-07: $85.54 per share

- 2026-08: $103.07 per share

- 2026-09: $105.30 per share

- 2026-10: $121.29 per share

## Annual estimated value (USD per share)

- FY2020: low $14.84 per share, central $17.49 per share, high $20.01 per share

- FY2021: low $15.73 per share, central $17.42 per share, high $19.69 per share

- FY2022: low $18.70 per share, central $20.64 per share, high $23.21 per share

- FY2023: low $29.61 per share, central $32.99 per share, high $37.49 per share

- FY2024: low $41.47 per share, central $47.94 per share, high $55.26 per share

- FY2025: low $45.08 per share, central $50.53 per share, high $57.79 per share

- FY2026: low $45.30 per share, central $50.91 per share, high $58.38 per share

Historical values use today's bond yield for every fiscal year

Historical values use today's FX rate into trading currency for every fiscal year

Historical values use current restated fundamentals and current commodity classification; they are not point-in-time estimates

## Sources

[Original 10-K filing](https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm); period 2026-03-28, filed 2026-05-20.

Estimates depend on assumptions and are not guarantees or investment advice. Underlying data remains subject to its source licenses; public reading does not grant bulk redistribution rights.